 |  |  |  |  |
 |  |  |  |  |
| Disease Group: | Leukemia
Lymphoma |  | Supported By: | none |
 |  |  |  |  |
| Phase of Study: | Phase II |  | Return
Visit: | Induction chemotherapy must be given at MDACC, then every 2-4 courses thereafter during intensive chemotherapy. |
 |  |  |  |  |
Treatment
Agents: | Methotrexate
ARA-C
Rituximab
Cyclophosphamide
Doxorubicin
Vincristine |  | Home Care: | Intensive chemotherapy courses will be prescribed by M.D.Anderson physician or PI. All chemotherapy treatment may be given by local oncologist except for the induction chemotherapy course. |
 |  |  |  |  |
| Treatment Loc: | both inpatient and outpatient |  |  |  |
 |  |  |  |  |
Estimated
Length of Stay
in Houston: | Four-five days for chemotherapy every 3 weeks; 21-28 days if in the protected environment for induction; 2-5 days if sepsis or other leukemia related event occurs. |  |  |  |